Study of Pamidronate for the Prevention of Heterotopic Ossification

Withdrawn University Hospital, Basel, Switzerland FAG (Freie Medizinische Gesellschaft) · collab

RandomizedParallel-groupOpen-labelPrevention

Summary

The purpose of this study is to determine whether Bisphosphonates in comparison to radiation therapy are effective in the prophylaxis and treatment of heterotopic ossification in high risk patients.

Timeline

Start: 2005-06
Primary completion: 2010-06
Completion: 2010-06

Publications

Background Schuetz P, Mueller B, Christ-Crain M, Dick W, Haas H. Amino-bisphosphonates in heterotopic ossification: first experience in five consecutive cases. Spinal Cord. 2005 Oct;43(10):604-10. doi: 10.1038/sj.sc.3101761.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pamidronate	Small molecule	1 mg/kg	Intravenous

Indications

No indication recorded.